# Spyre Therapeutics, Inc.: Form 8-K, filed Jun 15, 2026

- Company: [Spyre Therapeutics, Inc.](/companies/syre.md) (CIK 1636282)
- Form: 8-K
- Filed: 2026-06-15
- Accepted by EDGAR: Jun 15, 2026, 12:01 ET
- Period: 2026-06-15
- Accession: 0001636282-26-000083
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000083/syre-20260615.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000083/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636282/000163628226000083/syre-20260615.htm

Filed Jun 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001636282-26-000083. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.